2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2019-08-31
DOI
10.1093/eurheartj/ehz455
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial
- (2019) Michelle L. O'Donoghue et al. CIRCULATION
- Safety and Efficacy of Bempedoic Acid to Reduce LDL Cholesterol
- (2019) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
- (2019) Jane Armitage et al. LANCET
- Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease
- (2019) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial
- (2019) Kausik K Ray et al. Lancet Diabetes & Endocrinology
- Effect Modifications of Lipid-Lowering Therapy on Progression of Aortic Stenosis (from the Simvastatin and Ezetimibe in Aortic Stenosis [SEAS] Study)
- (2018) Anders M. Greve et al. AMERICAN JOURNAL OF CARDIOLOGY
- Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study
- (2018) Christie M. Ballantyne et al. ATHEROSCLEROSIS
- Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score”
- (2018) Philippe Moulin et al. ATHEROSCLEROSIS
- Bempedoic Acid (ETC-1002)
- (2018) Anum Saeed et al. CARDIOLOGY CLINICS
- Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the Treating to New Targets (TNT) Trial
- (2018) Antonio J. Vallejo-Vaz et al. CIRCULATION
- Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: An Analysis from FOURIER
- (2018) Marc S. Sabatine et al. CIRCULATION
- Comparison of fasting and non-fasting lipid profiles in a large cohort of patients presenting at a community hospital
- (2018) Louis-Jacques Cartier et al. CLINICAL BIOCHEMISTRY
- Quantifying Atherogenic Lipoproteins: Current and Future Challenges in the Era of Personalized Medicine and Very Low Concentrations of LDL Cholesterol. A Consensus Statement from EAS and EFLM
- (2018) Michel R. Langlois et al. CLINICAL CHEMISTRY
- Role of Anti-PCSK9 Antibodies in the Treatment of Patients with Statin Intolerance
- (2018) Julia Schreml et al. CURRENT MEDICINAL CHEMISTRY
- Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial
- (2018) Eiichi Araki et al. DIABETES CARE
- Effect of proprotein convertase subtilisin/kexin type 9 (PCSK9) monoclonal antibodies on new-onset diabetes mellitus and glucose metabolism: A systematic review and meta-analysis
- (2018) Ye-Xuan Cao et al. DIABETES OBESITY & METABOLISM
- Prognostic value of coronary computed tomographic angiography findings in asymptomatic individuals: a 6-year follow-up from the prospective multicentre international CONFIRM study
- (2018) Iksung Cho et al. EUROPEAN HEART JOURNAL
- Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract
- (2018) François Mach et al. EUROPEAN HEART JOURNAL
- Association Between Baseline LDL-C Level and Total and Cardiovascular Mortality After LDL-C Lowering
- (2018) Eliano P. Navarese et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome
- (2018) Otavio Berwanger et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Nontraditional Risk Factors in Cardiovascular Disease Risk Assessment
- (2018) Jennifer S. Lin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Omega-3 carboxylic acids in patients with severe hypertriglyceridemia: EVOLVE II, a randomized, placebo-controlled trial
- (2018) Erik S.G. Stroes et al. Journal of Clinical Lipidology
- Relationship of Lipoprotein(a) Molar Concentrations and Mass According to Lipoprotein(a) Thresholds and Apolipoprotein(a) Isoform Size
- (2018) Sotirios Tsimikas et al. Journal of Clinical Lipidology
- Effects of oils and solid fats on blood lipids: a systematic review and network meta-analysis
- (2018) Lukas Schwingshackl et al. JOURNAL OF LIPID RESEARCH
- Lipoprotein(a) and Cardiovascular Risk Prediction Among Women
- (2018) Nancy R. Cook et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies
- (2018) Angela M Wood et al. LANCET
- Expert consensus document: Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement
- (2018) Frédéric Brioude et al. Nature Reviews Endocrinology
- Retraction and Republication: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med 2013;368:1279-90.
- (2018) Ramón Estruch et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hypertriglyceridemia and omega-3 fatty acids: Their often overlooked role in cardiovascular disease prevention
- (2018) M. Arca et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper
- (2018) Andrea Poli et al. PHARMACOLOGICAL RESEARCH
- Statin Trials, Cardiovascular Events, and Coronary Artery Calcification
- (2018) Martin Bødtker Mortensen et al. JACC-Cardiovascular Imaging
- Dietary fat and cardiometabolic health: evidence, controversies, and consensus for guidance
- (2018) Nita G Forouhi et al. BMJ-British Medical Journal
- A Bayesian network meta-analysis of PCSK9 inhibitors, statins and ezetimibe with or without statins for cardiovascular outcomes
- (2018) Safi U Khan et al. European Journal of Preventive Cardiology
- Treatment of children with homozygous familial hypercholesterolaemia
- (2018) Željko Reiner European Journal of Preventive Cardiology
- Dietary fat and cardiometabolic health: evidence, controversies, and consensus for guidance
- (2018) Nita G Forouhi et al. BMJ-British Medical Journal
- Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks
- (2018) Theingi Aung et al. JAMA Cardiology
- Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies
- (2018) Stephen Burgess et al. JAMA Cardiology
- Assessment of omega-3 carboxylic acids in statin-treated patients with high levels of triglycerides and low levels of high-density lipoprotein cholesterol: Rationale and design of the STRENGTH trial
- (2018) Stephen J. Nicholls et al. CLINICAL CARDIOLOGY
- Impact of Lipids on Cardiovascular Health
- (2018) Brian A. Ference et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Association of dairy intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study
- (2018) Mahshid Dehghan et al. LANCET
- Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) Max G Griswold et al. LANCET
- Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus
- (2018) NEW ENGLAND JOURNAL OF MEDICINE
- Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study
- (2018) Aruna D. Pradhan et al. AMERICAN HEART JOURNAL
- Design of the randomized, placebo-controlled evolocumab for early reduction of LDL-cholesterol levels in patients with acute coronary syndromes (EVOPACS) trial
- (2018) Konstantinos C. Koskinas et al. CLINICAL CARDIOLOGY
- 2018 ESC/ESH Guidelines for the management of arterial hypertension
- (2018) Bryan Williams et al. JOURNAL OF HYPERTENSION
- Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer
- (2018) JoAnn E. Manson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-Dose Methotrexate for the Prevention of Atherosclerotic Events
- (2018) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Use of coronary artery calcium testing to improve coronary heart disease risk assessment in a lung cancer screening population: The Multi-Ethnic Study of Atherosclerosis (MESA)
- (2018) Parveen K. Garg et al. Journal of Cardiovascular Computed Tomography
- Effect of statins and non-statin LDL-lowering medications on cardiovascular outcomes in secondary prevention: a meta-analysis of randomized trials
- (2017) Konstantinos C Koskinas et al. EUROPEAN HEART JOURNAL
- Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995–2014
- (2017) Karolina Szummer et al. EUROPEAN HEART JOURNAL
- Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies
- (2017) Christian M. Madsen et al. EUROPEAN HEART JOURNAL
- ‘Highest risk–highest benefit’ strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies
- (2017) Lieven Annemans et al. EUROPEAN HEART JOURNAL
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial
- (2017) Nobuhisa Hagiwara et al. EUROPEAN HEART JOURNAL
- European Society of Cardiology: Cardiovascular Disease Statistics 2017
- (2017) et al. EUROPEAN HEART JOURNAL
- Reduction of low density lipoprotein-cholesterol and cardiovascular events with proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors and statins: an analysis of FOURIER, SPIRE, and the Cholesterol Treatment Trialists Collaboration
- (2017) Brian A Ference et al. EUROPEAN HEART JOURNAL
- Animal models of atherosclerosis
- (2017) Besa Emini Veseli et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Monocyte-Macrophages and T Cells in Atherosclerosis
- (2017) Ira Tabas et al. IMMUNITY
- The effects of bile acid sequestrants on lipid profile and blood glucose concentrations: A systematic review and meta-analysis of randomized controlled trials
- (2017) Mohsen Mazidi et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk
- (2017) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial
- (2017) Dhruv S. Kazi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lipid Lowering Therapy and Circulating PCSK9 Concentration
- (2017) Tsuyoshi Nozue Journal of Atherosclerosis and Thrombosis
- Evaluating the atherogenic burden of individuals with a Friedewald-estimated low-density lipoprotein cholesterol
- (2017) Seamus P. Whelton et al. Journal of Clinical Lipidology
- Lysosomal acid lipase deficiency: A hidden disease among cohorts of familial hypercholesterolemia?
- (2017) Joana Rita Chora et al. Journal of Clinical Lipidology
- Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity
- (2017) M.-R. Taskinen et al. JOURNAL OF INTERNAL MEDICINE
- A Test in Context: Lipoprotein(a)
- (2017) Sotirios Tsimikas JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cholesterol and Heart Failure
- (2017) Gary S. Francis JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure
- (2017) Antoni Bayes-Genis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Atherothrombotic Risk Stratification and Ezetimibe for Secondary Prevention
- (2017) Erin A. Bohula et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ANGPTL3 Deficiency and Protection Against Coronary Artery Disease
- (2017) Nathan O. Stitziel et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Safety of Very Low Low-Density Lipoprotein Cholesterol Levels With Alirocumab
- (2017) Jennifer G. Robinson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Underestimation of Low Density Lipoprotein-Cholesterol With the Friedewald Equation Versus a Direct Homogenous Low Density Lipoprotein-Cholesterol Assay
- (2017) Ishwarlal Jialal et al. Labmedicine
- Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial
- (2017) Amy L Ahern et al. LANCET
- Adverse events associated with unblinded, but not with blinded, statin therapy in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid-Lowering Arm (ASCOT-LLA): a randomised double-blind placebo-controlled trial and its non-randomised non-blind extension phase
- (2017) Ajay Gupta et al. LANCET
- Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
- (2017) Robert P Giugliano et al. LANCET
- Cognitive Function in a Randomized Trial of Evolocumab
- (2017) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease
- (2017) A. Michael Lincoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- ANGPTL3 Inhibition in Homozygous Familial Hypercholesterolemia
- (2017) Daniel Gaudet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mortality and Cardiovascular Disease in Type 1 and Type 2 Diabetes
- (2017) Aidin Rawshani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides
- (2017) Mark J. Graham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Highly Durable RNAi Therapeutic Inhibitor of PCSK9
- (2017) Kevin Fitzgerald et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
- (2017) Kausik K. Ray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Anacetrapib in Patients with Atherosclerotic Vascular Disease
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
- (2017) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- A systematic review of the effect of dietary saturated and polyunsaturated fat on heart disease
- (2017) P.M. Clifton et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Joint position statement on “Nutraceuticals for the treatment of hypercholesterolemia” of the Italian Society of Diabetology (SID) and of the Italian Society for the Study of Arteriosclerosis (SISA)
- (2017) M. Pirro et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- No benefits of statins for sudden cardiac death prevention in patients with heart failure and reduced ejection fraction: A meta-analysis of randomized controlled trials
- (2017) Muaamar Al-Gobari et al. PLoS One
- Statin Adherence Is Associated With Reduced Recurrent Stroke Risk in Patients With or Without Atrial Fibrillation
- (2017) Alexander C. Flint et al. STROKE
- Therapeutic strategies for atherosclerosis and atherothrombosis: Past, present and future
- (2017) Lina Badimon et al. THROMBOSIS AND HAEMOSTASIS
- Plaque Composition in the Proximal Superficial Femoral Artery and Peripheral Artery Disease Events
- (2017) Mary M. McDermott et al. JACC-Cardiovascular Imaging
- Implications of Coronary Artery Calcium Testing for Treatment Decisions Among Statin Candidates According to the ACC/AHA Cholesterol Management Guidelines
- (2017) Jonathan C. Hong et al. JACC-Cardiovascular Imaging
- Familial dysbetalipoproteinemia
- (2017) Charlotte Koopal et al. Current Opinion in Endocrinology Diabetes and Obesity
- Impact of Ezetimibe on the Rate of Cardiovascular-Related Hospitalizations and Associated Costs Among Patients With a Recent Acute Coronary Syndrome
- (2017) Yashashwi Pokharel et al. Circulation-Cardiovascular Quality and Outcomes
- Estimating the prevalence of heterozygous familial hypercholesterolaemia: a systematic review and meta-analysis
- (2017) Leo E Akioyamen et al. BMJ Open
- Carotid plaque thickness and carotid plaque burden predict future cardiovascular events in asymptomatic adult Americans
- (2017) Henrik Sillesen et al. European Heart Journal-Cardiovascular Imaging
- Early, intensive statin treatment reduces ‘hard’ cardiovascular outcomes after acute coronary syndrome
- (2017) Gregory G Schwartz et al. European Journal of Preventive Cardiology
- Food supplements with red yeast rice: More regulations are needed
- (2017) Guy G De Backer European Journal of Preventive Cardiology
- Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
- (2017) Marc S Sabatine et al. Lancet Diabetes & Endocrinology
- PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study
- (2017) Amand F Schmidt et al. Lancet Diabetes & Endocrinology
- Underestimation of Low Density Lipoprotein-Cholesterol With the Friedewald Equation Versus a Direct Homogenous Low Density Lipoprotein-Cholesterol Assay
- (2017) Ishwarlal Jialal et al. LABORATORY MEDICINE
- Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes
- (2017) Marshall B. Elam et al. JAMA Cardiology
- National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013
- (2017) Joseph A. Salami et al. JAMA Cardiology
- Updated Cost-effectiveness Assessments of PCSK9 Inhibitors From the Perspectives of the Health System and Private Payers
- (2017) Alejandro Arrieta et al. JAMA Cardiology
- Cost-effectiveness of PCSK9 Inhibitors
- (2017) Robert O. Bonow et al. JAMA Cardiology
- Cost-effectiveness of Evolocumab Therapy for Reducing Cardiovascular Events in Patients With Atherosclerotic Cardiovascular Disease
- (2017) Gregg C. Fonarow et al. JAMA Cardiology
- Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor)
- (2017) Aurélie Thedrez et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease
- (2017) Marc P. Bonaca et al. CIRCULATION
- Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus
- (2017) Robert P. Giugliano et al. CIRCULATION
- Fasting Versus Nonfasting and Low-Density Lipoprotein Cholesterol Accuracy
- (2017) Vasanth Sathiyakumar et al. CIRCULATION
- Prevention of contrast-induced acute kidney injury in patients undergoing cardiovascular procedures-a systematic review and network meta-analysis
- (2017) Eliano P. Navarese et al. PLoS One
- Low-Density Lipoprotein Cholesterol, Non–High-Density Lipoprotein Cholesterol, Triglycerides, and Apolipoprotein B and Cardiovascular Risk in Patients With Manifest Arterial Disease
- (2016) M. Johanneke van den Berg et al. AMERICAN JOURNAL OF CARDIOLOGY
- Dairy fat and risk of cardiovascular disease in 3 cohorts of US adults
- (2016) Mu Chen et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Proprotein Convertase Subtilisin/Kexin Type 9 Monoclonal Antibodies for Acute Coronary Syndrome
- (2016) Eliano P. Navarese et al. ANNALS OF INTERNAL MEDICINE
- Comparative Efficacy and Safety of Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stents
- (2016) Xin-Lin Zhang et al. ANNALS OF INTERNAL MEDICINE
- The effect of statins on valve function and calcification in aortic stenosis: A meta-analysis
- (2016) Ying Zhao et al. ATHEROSCLEROSIS
- Effect of monoclonal antibodies to PCSK9 on high-sensitivity C-reactive protein levels: a meta-analysis of 16 randomized controlled treatment arms
- (2016) Amirhossein Sahebkar et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study
- (2016) Leslie Cho et al. CARDIOVASCULAR DRUGS AND THERAPY
- Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin TherapyCLINICAL PERSPECTIVE
- (2016) Ian Ford et al. CIRCULATION
- Oxidized Phospholipids on Lipoprotein(a) Elicit Arterial Wall Inflammation and an Inflammatory Monocyte Response in HumansClinical Perspective
- (2016) Fleur M. van der Valk et al. CIRCULATION
- Prevalence of Familial Hypercholesterolemia in the 1999 to 2012 United States National Health and Nutrition Examination Surveys (NHANES)CLINICAL PERSPECTIVE
- (2016) Sarah D. de Ferranti et al. CIRCULATION
- Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112Novelty and Significance
- (2016) Svetlana A. Didichenko et al. CIRCULATION RESEARCH
- Why Is Apolipoprotein CIII Emerging as a Novel Therapeutic Target to Reduce the Burden of Cardiovascular Disease?
- (2016) Marja-Riitta Taskinen et al. Current Atherosclerosis Reports
- Niemann-Pick C1-Like 1 (NPC1L1) Inhibition and Cardiovascular Diseases
- (2016) A. Pirillo et al. CURRENT MEDICINAL CHEMISTRY
- Combined hyperlipidemia
- (2016) Amanda J. Brahm et al. CURRENT OPINION IN LIPIDOLOGY
- The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis
- (2016) Jan Borén et al. CURRENT OPINION IN LIPIDOLOGY
- Antisense-Mediated Lowering of Plasma Apolipoprotein C-III by Volanesorsen Improves Dyslipidemia and Insulin Sensitivity in Type 2 Diabetes
- (2016) Andres Digenio et al. DIABETES CARE
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice
- (2016) Massimo F. Piepoli et al. EUROPEAN HEART JOURNAL
- 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
- (2016) Alberico L. Catapano et al. EUROPEAN HEART JOURNAL
- Non-alcoholic fatty liver disease as driving force in coronary heart disease?
- (2016) Giovanni Targher GUT
- Very low LDL-C levels may safely provide additional clinical cardiovascular benefit: the evidence to date
- (2016) Terry McCormack et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
- (2016) Michael G. Silverman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Prevalence and Prognostic Implications of Coronary Artery Calcification in Low-Risk Women
- (2016) Maryam Kavousi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance
- (2016) Steven E. Nissen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
- (2016) Philip L.S.M. Gordts et al. JOURNAL OF CLINICAL INVESTIGATION
- Triglyceride-lowering therapies reduce cardiovascular disease event risk in subjects with hypertriglyceridemia
- (2016) Kevin C. Maki et al. Journal of Clinical Lipidology
- The risks of statin use in pregnancy: A systematic review
- (2016) Dean G. Karalis et al. Journal of Clinical Lipidology
- Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology
- (2016) Børge G. Nordestgaard et al. JOURNAL OF LIPID RESEARCH
- Determining When to Add Nonstatin Therapy
- (2016) Jennifer G. Robinson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome
- (2016) Sabina A. Murphy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Weight Loss Interventions in Older Adults with Obesity: A Systematic Review of Randomized Controlled Trials Since 2005
- (2016) John A. Batsis et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Interpretation of the evidence for the efficacy and safety of statin therapy
- (2016) Rory Collins et al. LANCET
- Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
- (2016) Nicholas J Viney et al. LANCET
- Perioperative Rosuvastatin in Cardiac Surgery
- (2016) Zhe Zheng et al. NEW ENGLAND JOURNAL OF MEDICINE
- Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes
- (2016) Brian A. Ference et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta-analysis
- (2016) E. Zomer et al. Obesity Reviews
- High Dose Atorvastatin Associated with Increased Risk of Significant Hepatotoxicity in Comparison to Simvastatin in UK GPRD Cohort
- (2016) Alan T. Clarke et al. PLoS One
- Therapeutic Targets of Triglyceride Metabolism as Informed by Human Genetics
- (2016) Robert C. Bauer et al. TRENDS IN MOLECULAR MEDICINE
- Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions
- (2016) Kornelia Kotseva et al. European Journal of Preventive Cardiology
- The Contribution of GWAS Loci in Familial Dyslipidemias
- (2016) Pietari Ripatti et al. PLoS Genetics
- How Well Can We Control Dyslipidemias Through Lifestyle Modifications?
- (2016) Gabriele Riccardi et al. Current Cardiology Reports
- Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study
- (2016) Jack R W Brownrigg et al. Lancet Diabetes & Endocrinology
- Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials
- (2016) Lancet Diabetes & Endocrinology
- Association Between Cardiac Rehabilitation Participation and Health Status Outcomes After Acute Myocardial Infarction
- (2016) Faraz Kureshi et al. JAMA Cardiology
- Metabolic consequences of modern immunosuppressive agents in solid organ transplantation
- (2016) Oluwatoyin Bamgbola Therapeutic Advances in Endocrinology and Metabolism
- Usefulness of Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein Cholesterol as Predictors of Cardiovascular Disease in Chinese
- (2015) Xiaoying Gu et al. AMERICAN JOURNAL OF CARDIOLOGY
- A dose-response study of consuming high-fructose corn syrup–sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults
- (2015) Kimber L Stanhope et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Whole-grain and blood lipid changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies1–3
- (2015) Pernille LB Hollænder et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Dietary cholesterol and cardiovascular disease: a systematic review and meta-analysis
- (2015) Samantha Berger et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention
- (2015) Goran Loncar et al. Archives of Cardiovascular Diseases
- Kinetic and Related Determinants of Plasma Triglyceride Concentration in Abdominal ObesitySignificance
- (2015) Jan Borén et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary
- (2015) Laszlo Mark et al. ATHEROSCLEROSIS
- New insights into the pathophysiology of dyslipidemia in type 2 diabetes
- (2015) Marja-Riitta Taskinen et al. ATHEROSCLEROSIS
- The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation
- (2015) Charalambos Vlachopoulos et al. ATHEROSCLEROSIS
- Achievement of Dual Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein Targets More Frequent With the Addition of Ezetimibe to Simvastatin and Associated With Better Outcomes in IMPROVE-ITCLINICAL PERSPECTIVES
- (2015) Erin A. Bohula et al. CIRCULATION
- A comprehensive meta-analysis on evidence of Mediterranean diet and cardiovascular disease: Are individual components equal?
- (2015) Giuseppe Grosso et al. CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
- Dysbetalipoproteinemia
- (2015) David Marais CURRENT OPINION IN LIPIDOLOGY
- Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort
- (2015) Henna Cederberg et al. DIABETOLOGIA
- Characterization of Clinical and Genetic Risk Factors Associated with Dyslipidemia after Kidney Transplantation
- (2015) Kazuyuki Numakura et al. DISEASE MARKERS
- Hypertriglyceridemia in the Genomic Era: A New Paradigm
- (2015) Gary F. Lewis et al. ENDOCRINE REVIEWS
- Naturaltransfat, dairy fat, partially hydrogenated oils, and cardiometabolic health: the Ludwigshafen Risk and Cardiovascular Health Study: Table 1
- (2015) Dariush Mozaffarian EUROPEAN HEART JOURNAL
- The effect of statin therapy on heart failure events: a collaborative meta-analysis of unpublished data from major randomized trials
- (2015) David Preiss et al. EUROPEAN HEART JOURNAL
- The impact of proprotein convertase subtilisin-kexin type 9 serine protease inhibitors on lipid levels and outcomes in patients with primary hypercholesterolaemia: a network meta-analysis
- (2015) Michael J. Lipinski et al. EUROPEAN HEART JOURNAL
- Cardiovascular disease in Europe — epidemiological update 2015
- (2015) Nick Townsend et al. EUROPEAN HEART JOURNAL
- Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
- (2015) Albert Wiegman et al. EUROPEAN HEART JOURNAL
- Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management
- (2015) Erik S. Stroes et al. EUROPEAN HEART JOURNAL
- Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF
- (2015) Matthew J. Feinstein et al. EUROPEAN JOURNAL OF HEART FAILURE
- Effects of add-on lipid-modifying therapy on top of background statin treatment on major cardiovascular events: A meta-analysis of randomized controlled trials
- (2015) Chi-kin Ip et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease
- (2015) Ankur Pandya et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial
- (2015) Patrick M. Moriarty et al. Journal of Clinical Lipidology
- Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension
- (2015) Jiarong Lan et al. JOURNAL OF ETHNOPHARMACOLOGY
- Statin use and non-alcoholic steatohepatitis in at risk individuals
- (2015) Paola Dongiovanni et al. JOURNAL OF HEPATOLOGY
- Lipoprotein (a) measurements for clinical application
- (2015) Santica M. Marcovina et al. JOURNAL OF LIPID RESEARCH
- Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention
- (2015) Kenichi Tsujita et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of Naturally Random Allocation to Lower Low-Density Lipoprotein Cholesterol on the Risk of Coronary Heart Disease Mediated by Polymorphisms in NPC1L1, HMGCR, or Both
- (2015) Brian A. Ference et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Prevalence, Impact, and Predictive Value of Detecting Subclinical Coronary and Carotid Atherosclerosis in Asymptomatic Adults
- (2015) Usman Baber et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
- (2015) Daniel I Swerdlow et al. LANCET
- Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome
- (2015) Charles Daniel Meyers et al. Lipids in Health and Disease
- A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease
- (2015) Majid Nikpay et al. NATURE GENETICS
- Chylomicronaemia—current diagnosis and future therapies
- (2015) Amanda J. Brahm et al. Nature Reviews Endocrinology
- Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
- (2015) Jennifer G. Robinson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Demographic and Epidemiologic Drivers of Global Cardiovascular Mortality
- (2015) Gregory A. Roth et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency
- (2015) Barbara K. Burton et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of Evolocumab in Reducing Lipids and Cardiovascular Events
- (2015) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries
- (2015) Emelie Heintz et al. PHARMACOECONOMICS
- Cardiovascular risk estimation in older persons: SCORE O.P.
- (2015) Marie Therese Cooney et al. European Journal of Preventive Cardiology
- A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys
- (2015) Kaveh Hajifathalian et al. Lancet Diabetes & Endocrinology
- Comparing Different Policy Scenarios to Reduce the Consumption of Ultra-Processed Foods in UK: Impact on Cardiovascular Disease Mortality Using a Modelling Approach
- (2015) Patricia V. L. Moreira et al. PLoS One
- Effect of Alirocumab, a Monoclonal Proprotein Convertase Subtilisin/Kexin 9 Antibody, on Lipoprotein(a) Concentrations (a Pooled Analysis of 150 mg Every Two Weeks Dosing from Phase 2 Trials)
- (2014) Daniel Gaudet et al. AMERICAN JOURNAL OF CARDIOLOGY
- Meta-Analysis of Time-Related Benefits of Statin Therapy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
- (2014) Eliano Pio Navarese et al. AMERICAN JOURNAL OF CARDIOLOGY
- Impact of High-Dose Atorvastatin Therapy and Clinical Risk Factors on Incident Aortic Valve Stenosis in Patients With Cardiovascular Disease (from TNT, IDEAL, and SPARCL)
- (2014) Benoit J. Arsenault et al. AMERICAN JOURNAL OF CARDIOLOGY
- Mipomersen is a Promising Therapy in the Management of Hypercholesterolemia: A Meta-Analysis of Randomized Controlled Trials
- (2014) Na Li et al. American Journal of Cardiovascular Drugs
- Diets to Prevent Coronary Heart Disease 1957-2013: What Have We Learned?
- (2014) James E. Dalen et al. AMERICAN JOURNAL OF MEDICINE
- The Cost-Effectiveness of New York City’s Safe Routes to School Program
- (2014) Peter A. Muennig et al. AMERICAN JOURNAL OF PUBLIC HEALTH
- Lipid Management in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2013 Clinical Practice Guideline
- (2014) Marcello Tonelli et al. ANNALS OF INTERNAL MEDICINE
- Association of Dietary, Circulating, and Supplement Fatty Acids With Coronary Risk
- (2014) Rajiv Chowdhury et al. ANNALS OF INTERNAL MEDICINE
- Combination therapy in dyslipidemia: Where are we now?
- (2014) Alberico L. Catapano et al. ATHEROSCLEROSIS
- Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group
- (2014) Michel R. Langlois et al. ATHEROSCLEROSIS
- Is there a linear relationship between the dose of ruminant trans-fatty acids and cardiovascular risk markers in healthy subjects: results from a systematic review and meta-regression of randomised clinical trials
- (2014) Constance Gayet-Boyer et al. BRITISH JOURNAL OF NUTRITION
- Prognostic Value of Fasting Versus Nonfasting Low-Density Lipoprotein Cholesterol Levels on Long-Term Mortality
- (2014) Bethany Doran et al. CIRCULATION
- Validation of a Proposed Novel Equation for Estimating LDL Cholesterol
- (2014) J. W. Meeusen et al. CLINICAL CHEMISTRY
- The Role of Antisense Oligonucleotide Therapy in Patients with Familial Hypercholesterolemia: Risks, Benefits, and Management Recommendations
- (2014) Anandita Agarwala et al. Current Atherosclerosis Reports
- Lack of effect of colesevelam HCl on the single-dose pharmacokinetics of aspirin, atenolol, enalapril, phenytoin, rosiglitazone, and sitagliptin
- (2014) Ling He et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Favourable effects of fenofibrate on lipids and cardiovascular disease in women with type 2 diabetes: results from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
- (2014) Michael C. d’Emden et al. DIABETOLOGIA
- Mendelian randomization of blood lipids for coronary heart disease
- (2014) Michael V. Holmes et al. EUROPEAN HEART JOURNAL
- Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
- (2014) M. Cuchel et al. EUROPEAN HEART JOURNAL
- Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial
- (2014) J.-C. Tardif et al. EUROPEAN HEART JOURNAL
- Safety and tolerability of injectable lipid-lowering drugs: a review of available clinical data
- (2014) Arrigo FG Cicero et al. Expert Opinion On Drug Safety
- The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review
- (2014) E Loveman et al. HEALTH TECHNOLOGY ASSESSMENT
- Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)
- (2014) HEART
- Evaluation and Treatment of Older Patients With Hypercholesterolemia
- (2014) Timo E. Strandberg et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Association of Low-Density Lipoprotein Cholesterol–Related Genetic Variants With Aortic Valve Calcium and Incident Aortic Stenosis
- (2014) J. Gustav Smith et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Efficacy and safety of alirocumab, a monoclonal antibody to PCSK9, in statin-intolerant patients: Design and rationale of ODYSSEY ALTERNATIVE, a randomized phase 3 trial
- (2014) Patrick M. Moriarty et al. Journal of Clinical Lipidology
- An assessment by the Statin Liver Safety Task Force: 2014 update
- (2014) Harold Bays et al. Journal of Clinical Lipidology
- Discrimination and Net Reclassification of Cardiovascular Risk With Lipoprotein(a)
- (2014) Peter Willeit et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events
- (2014) S. Matthijs Boekholdt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance
- (2014) Erik Stroes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145)
- (2014) Frederick J. Raal et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Triglycerides and cardiovascular disease
- (2014) Børge G Nordestgaard et al. LANCET
- Changes in Diabetes-Related Complications in the United States, 1990–2010
- (2014) Edward W. Gregg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Inactivating Mutations in NPC1L1 and Protection from Coronary Heart Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Association of fructose consumption and components of metabolic syndrome in human studies: A systematic review and meta-analysis
- (2014) Roya Kelishadi et al. NUTRITION
- Resistance and intolerance to statins
- (2014) Ž. Reiner NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- A Cost Effectiveness Analysis of Salt Reduction Policies to Reduce Coronary Heart Disease in Four Eastern Mediterranean Countries
- (2014) Helen Mason et al. PLoS One
- A Meta-Analysis of Red Yeast Rice: An Effective and Relatively Safe Alternative Approach for Dyslipidemia
- (2014) Yinhua Li et al. PLoS One
- An Economic Evaluation of Salt Reduction Policies to Reduce Coronary Heart Disease in England: A Policy Modeling Study
- (2014) Marissa Collins et al. VALUE IN HEALTH
- Baseline Very Low-Density Lipoprotein Cholesterol is Associated with the Magnitude of Triglyceride Lowering on Statins, Fenofibric Acid, or Their Combination in Patients with Mixed Dyslipidemia
- (2014) Abhinav Sharma et al. Journal of Cardiovascular Translational Research
- Explaining trends in Scottish coronary heart disease mortality between 2000 and 2010 using IMPACTSEC model: retrospective analysis using routine data
- (2014) J. W. Hotchkiss et al. BMJ-British Medical Journal
- Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients
- (2014) D. Keene et al. BMJ-British Medical Journal
- Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys
- (2014) R. Micha et al. BMJ-British Medical Journal
- What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice
- (2014) Judith A Finegold et al. European Journal of Preventive Cardiology
- Peripheral artery disease is a coronary heart disease risk equivalent among both men and women: results from a nationwide study
- (2014) Sumeet Subherwal et al. European Journal of Preventive Cardiology
- Effect of Rosuvastatin on Repeat Heart Failure Hospitalizations
- (2014) Jennifer K. Rogers et al. JACC-Heart Failure
- Role of Colesevelam in Combination Lipid-Lowering Therapy
- (2013) Michael R. Jones et al. American Journal of Cardiovascular Drugs
- Evaluation of Newer Risk Markers for Coronary Heart Disease Risk Classification
- (2013) Maryam Kavousi et al. ANNALS OF INTERNAL MEDICINE
- Plasma Phospholipid Long-Chain ω-3 Fatty Acids and Total and Cause-Specific Mortality in Older Adults
- (2013) Dariush Mozaffarian et al. ANNALS OF INTERNAL MEDICINE
- Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
- (2013) Paul E. Stevens ANNALS OF INTERNAL MEDICINE
- Intermittent Nondaily Dosing Strategies in Patients with Previous Statin-Induced Myopathy
- (2013) Alyssa J Keating et al. ANNALS OF PHARMACOTHERAPY
- Targeting PCSK9 for Hypercholesterolemia
- (2013) Giuseppe Danilo Norata et al. Annual Review of Pharmacology and Toxicology
- Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease
- (2013) Helena Gylling et al. ATHEROSCLEROSIS
- Explaining the decline in coronary heart disease mortality in Turkey between 1995 and 2008
- (2013) Belgin Unal et al. BMC PUBLIC HEALTH
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. CIRCULATION
- 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
- (2013) Robert H. Eckel et al. CIRCULATION
- Lipoprotein(a) Concentrations, Rosuvastatin Therapy, and Residual Vascular Risk
- (2013) Amit V. Khera et al. CIRCULATION
- Apolipoprotein C-III
- (2013) Murray W. Huff et al. CIRCULATION RESEARCH
- Antisense Oligonucleotide Inhibition of Apolipoprotein C-III Reduces Plasma Triglycerides in Rodents, Nonhuman Primates, and Humans
- (2013) Mark J. Graham et al. CIRCULATION RESEARCH
- Comparative Tolerability and Harms of Individual Statins
- (2013) Huseyin Naci et al.
- Explaining the Decline in Coronary Heart Disease Mortality in Portugal Between 1995 and 2008
- (2013) Marta Pereira et al.
- Acute Coronary Syndromes in Patients with Chronic Kidney Disease
- (2013) Beata Franczyk-Skóra et al. Current Vascular Pharmacology
- Colesevelam for Type 2 diabetes mellitus: an abridged Cochrane review*
- (2013) C. P. Ooi et al. DIABETIC MEDICINE
- Revisiting the links between glycaemia, diabetes and cardiovascular disease
- (2013) N. Sattar DIABETOLOGIA
- Persisting gender differences and attenuating age differences in cardiovascular drug use for prevention and treatment of coronary heart disease, 1998–2010
- (2013) Carla Koopman et al. EUROPEAN HEART JOURNAL
- Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study
- (2013) A. McConnachie et al. EUROPEAN HEART JOURNAL
- Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
- (2013) B. G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- High-sensitivity C-reactive protein and atherosclerotic disease: From improved risk prediction to risk-guided therapy
- (2013) Wolfgang Koenig INTERNATIONAL JOURNAL OF CARDIOLOGY
- The risk of atherosclerosis in patients with chronic kidney disease
- (2013) Sylwia Olechnowicz-Tietz et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial
- (2013) John J.P. Kastelein et al. Journal of Clinical Lipidology
- Friedewald-Estimated Versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications
- (2013) Seth S. Martin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction
- (2013) Pia R. Kamstrup et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial
- (2013) Theodore M. Brasky et al. JNCI-Journal of the National Cancer Institute
- Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
- (2013) Ron T Gansevoort et al. LANCET
- Effects of ezetimibe on markers of synthesis and absorption of cholesterol in high-risk patients with elevated C-reactive protein
- (2013) Simone P. Barbosa et al. LIFE SCIENCES
- Type 1 diabetes, metabolic syndrome and cardiovascular risk
- (2013) Juan J. Chillarón et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Discovery and refinement of loci associated with lipid levels
- (2013) Cristen J Willer et al. NATURE GENETICS
- Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- A daily glass of red wine associated with lifestyle changes independentlyimproves blood lipids in patients with carotid arteriosclerosis: results from arandomized controlled trial
- (2013) Dirk W Droste et al. Nutrition Journal
- Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: A clinical update
- (2013) Ž. Reiner NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- A prospective cohort study on risk of acute pancreatitis related to serum triglycerides, cholesterol and fasting glucose
- (2013) Björn Lindkvist et al. PANCREATOLOGY
- Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy—A meta-analysis of 11 randomized controlled trials involving 21,295 participants
- (2013) Marcin Barylski et al. PHARMACOLOGICAL RESEARCH
- Mediterranean diet and health status: an updated meta-analysis and a proposal for a literature-based adherence score
- (2013) Francesco Sofi et al. PUBLIC HEALTH NUTRITION
- Reduction in Early Stroke Risk in Carotid Stenosis With Transient Ischemic Attack Associated With Statin Treatment
- (2013) Áine Merwick et al. STROKE
- Modelling the impact of specific food policy options on coronary heart disease and stroke deaths in Ireland
- (2013) Celine O'Keeffe et al. BMJ Open
- Comparative benefits of statins in the primary and secondary prevention of major coronary events and all-cause mortality: a network meta-analysis of placebo-controlled and active-comparator trials
- (2013) Huseyin Naci et al. European Journal of Preventive Cardiology
- Monitoring of Lipids, Enzymes, and Creatine Kinase in Patients on Lipid-Lowering Drug Therapy
- (2013) Olov Wiklund et al. Current Cardiology Reports
- The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
- (2013) Robert A Hegele et al. Lancet Diabetes & Endocrinology
- Exercise effects on lipids in persons with varying dietary patterns—does diet matter if they exercise? Responses in Studies of a Targeted Risk Reduction Intervention through Defined Exercise I
- (2012) Kim M. Huffman et al. AMERICAN HEART JOURNAL
- Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)
- (2012) Christie M. Ballantyne et al. AMERICAN JOURNAL OF CARDIOLOGY
- FDA Drug Safety Communications: A Narrative Review and Clinical Considerations for Older Adults
- (2012) Zachary A. Marcum et al. American Journal Geriatric Pharmacotherapy
- Dyslipidemia and Its Therapeutic Challenges in Renal Transplantation
- (2012) L. V. Riella et al. AMERICAN JOURNAL OF TRANSPLANTATION
- A multicenter study on the precision and accuracy of homogeneous assays for LDL-cholesterol: Comparison with a beta-quantification method using fresh serum obtained from non-diseased and diseased subjects
- (2012) Takashi Miida et al. ATHEROSCLEROSIS
- Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: A pooled analysis of over 21,000 subjects from 27 clinical trials
- (2012) Doralisa Morrone et al. ATHEROSCLEROSIS
- Discordance analysis of Apolipoprotein B and non-high density lipoprotein cholesterol as markers of cardiovascular risk in the INTERHEART study
- (2012) Allan D. Sniderman et al. ATHEROSCLEROSIS
- Body Fat Distribution and Risk of Cardiovascular Disease
- (2012) Jean-Pierre Després CIRCULATION
- Genetic Determinants of Statin-Induced Low-Density Lipoprotein Cholesterol Reduction
- (2012) Daniel I. Chasman et al. Circulation-Cardiovascular Genetics
- Better treatment and improved prognosis in elderly patients with AMI: but do registers tell the whole truth?
- (2012) A. Rosengren EUROPEAN HEART JOURNAL
- Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction
- (2012) Anders Berg Jørgensen et al. EUROPEAN HEART JOURNAL
- Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial
- (2012) D Gaudet et al. GENE THERAPY
- Lipid-Modifying Therapies and Risk of Pancreatitis
- (2012) David Preiss et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Common Carotid Intima-Media Thickness Measurements in Cardiovascular Risk Prediction
- (2012) Hester M. Den Ruijter et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparison of Novel Risk Markers for Improvement in Cardiovascular Risk Assessment in Intermediate-Risk Individuals
- (2012) Joseph Yeboah et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of Fibrates in Kidney Disease
- (2012) Min Jun et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of Long-Term Exposure to Lower Low-Density Lipoprotein Cholesterol Beginning Early in Life on the Risk of Coronary Heart Disease
- (2012) Brian A. Ference et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Event Reduction Versus New-Onset Diabetes During Atorvastatin Therapy
- (2012) David D. Waters et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease
- (2012) Anette Varbo et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data
- (2012) Matthias W Lorenz et al. LANCET
- Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
- (2012) Benjamin F Voight et al. LANCET
- Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study
- (2012) Marina Cuchel et al. LANCET
- Lifetime Risks of Cardiovascular Disease
- (2012) Jarett D. Berry et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
- (2012) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Systematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors
- (2012) F. L. Santos et al. Obesity Reviews
- Which Interventions Offer Best Value for Money in Primary Prevention of Cardiovascular Disease?
- (2012) Linda J. Cobiac et al. PLoS One
- Statin Therapy and the Risk of Intracerebral Hemorrhage
- (2012) James S. McKinney et al. STROKE
- Population-level changes to promote cardiovascular health
- (2012) Torben Jørgensen et al. European Journal of Preventive Cardiology
- Effect of Statins on Venous Thromboembolic Events: A Meta-analysis of Published and Unpublished Evidence from Randomised Controlled Trials
- (2012) Kazem Rahimi et al. PLOS MEDICINE
- Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Patients With Very High Triglyceride Levels (from the Multi-center, plAcebo-controlled, Randomized, double-blINd, 12-week study with an open-label Extension [MARINE] Trial)
- (2011) Harold E. Bays et al. AMERICAN JOURNAL OF CARDIOLOGY
- Pleiotropic Effects of Statins
- (2011) Terje R. Pedersen American Journal of Cardiovascular Drugs
- Cost-effectiveness of enhancing adherence to therapy with statins in the setting of primary cardiovascular prevention. Evidence from an empirical approach based on administrative databases
- (2011) Giovanni Corrao et al. ATHEROSCLEROSIS
- Efficacy of fibrates for cardiovascular risk reduction in persons with atherogenic dyslipidemia: A meta-analysis
- (2011) Meng Lee et al. ATHEROSCLEROSIS
- Components of a Cardioprotective Diet
- (2011) Dariush Mozaffarian et al. CIRCULATION
- Clinical Benefit of Statin Pretreatment in Patients Undergoing Percutaneous Coronary Intervention
- (2011) Giuseppe Patti et al. CIRCULATION
- Statins and Intracerebral Hemorrhage
- (2011) Daniel G. Hackam et al. CIRCULATION
- Non-HDL Cholesterol Shows Improved Accuracy for Cardiovascular Risk Score Classification Compared to Direct or Calculated LDL Cholesterol in a Dyslipidemic Population
- (2011) H. E. van Deventer et al. CLINICAL CHEMISTRY
- Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis
- (2011) Melissa Y. Wei et al. Current Atherosclerosis Reports
- Diagnostic Value of Postprandial Triglyceride Testing in Healthy Subjects:A Meta-Analysis
- (2011) Constantinos Mihas et al. Current Vascular Pharmacology
- Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel Statement
- (2011) Genovefa D. Kolovou et al. Current Vascular Pharmacology
- Higher Tacrolimus Blood Concentration Is Related to Hyperlipidemia in Living Donor Liver Transplantation Recipients
- (2011) Hong-Yu Li et al. DIGESTIVE DISEASES AND SCIENCES
- Intensive statin therapy compared with moderate dosing for prevention of cardiovascular events: a meta-analysis of >40 000 patients
- (2011) Edward J. Mills et al. EUROPEAN HEART JOURNAL
- ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries * The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC)
- (2011) et al. EUROPEAN HEART JOURNAL
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Cost-effectiveness of diet and exercise interventions to reduce overweight and obesity
- (2011) M Forster et al. INTERNATIONAL JOURNAL OF OBESITY
- Risk of Incident Diabetes With Intensive-Dose Compared With Moderate-Dose Statin Therapy
- (2011) David Preiss JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: A review
- (2011) Terry A. Jacobson et al. Journal of Clinical Lipidology
- Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing
- (2011) Einar Björnsson et al. JOURNAL OF HEPATOLOGY
- Cardiovascular Event Reduction and Adverse Events Among Subjects Attaining Low-Density Lipoprotein Cholesterol
- (2011) Judith Hsia et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Effect of Mediterranean Diet on Metabolic Syndrome and its Components
- (2011) Christina-Maria Kastorini et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Medication Adherence: WHO Cares?
- (2011) Marie T. Brown et al. MAYO CLINIC PROCEEDINGS
- Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: evidence from the Symphony study
- (2011) K. Claes et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Weighing the Benefits of High-Dose Simvastatin against the Risk of Myopathy
- (2011) Amy Egan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- A comparison of the LDL-cholesterol lowering efficacy of plant stanols and plant sterols over a continuous dose range: Results of a meta-analysis of randomized, placebo-controlled trials
- (2011) Kathy Musa-Veloso et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
- (2010) SHARP Collaborative Group AMERICAN HEART JOURNAL
- A Framework for Public Health Action: The Health Impact Pyramid
- (2010) Thomas R. Frieden AMERICAN JOURNAL OF PUBLIC HEALTH
- Statins and All-Cause Mortality in High-Risk Primary Prevention
- (2010) Kausik K. Ray ARCHIVES OF INTERNAL MEDICINE
- Cardiovascular Risk-Estimation Systems in Primary Prevention
- (2010) Marie Therese Cooney et al. CIRCULATION
- Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary Syndromes
- (2010) Clara K. Chow et al. CIRCULATION
- Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or Dyslipidemia
- (2010) Samia Mora et al. CIRCULATION
- Effect of Lipid Lowering With Rosuvastatin on Progression of Aortic Stenosis
- (2010) Kwan Leung Chan et al. CIRCULATION
- Seven Direct Methods for Measuring HDL and LDL Cholesterol Compared with Ultracentrifugation Reference Measurement Procedures
- (2010) W. G. Miller et al. CLINICAL CHEMISTRY
- Cardiac computed tomography and myocardial perfusion scintigraphy for risk stratification in asymptomatic individuals without known cardiovascular disease: a position statement of the Working Group on Nuclear Cardiology and Cardiac CT of the European Society of Cardiology
- (2010) P. Perrone-Filardi et al. EUROPEAN HEART JOURNAL
- Is carotid intima media thickness useful for individual prediction of cardiovascular risk? Ten-year results from the Carotid Atherosclerosis Progression Study (CAPS)
- (2010) M. W. Lorenz et al. EUROPEAN HEART JOURNAL
- Lipoprotein(a) as a cardiovascular risk factor: current status
- (2010) Børge G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Statins and renovascular disease in the elderly: a population-based cohort study
- (2010) D. G. Hackam et al. EUROPEAN HEART JOURNAL
- Efficacy of High-Dose Atorvastatin Loading Before Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction
- (2010) Jung-Sun Kim et al. JACC-Cardiovascular Interventions
- Fibrates Effect on Cardiovascular Risk Is Greater in Patients With High Triglyceride Levels or Atherogenic Dyslipidemia Profile: A Systematic Review and Meta-analysis
- (2010) Eric Bruckert et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
- (2010) The Emerging Risk Factors Collaboration LANCET
- Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies
- (2010) LANCET
- Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
- (2010) Naveed Sattar et al. LANCET
- Diagnosis and treatment of apolipoprotein B dyslipoproteinemias
- (2010) Allan Sniderman et al. Nature Reviews Endocrinology
- Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Niacin and fibrates in atherogenic dyslipidemia: Pharmacotherapy to reduce cardiovascular risk
- (2010) M. John Chapman et al. PHARMACOLOGY & THERAPEUTICS
- Analysing the Large Decline in Coronary Heart Disease Mortality in the Icelandic Population Aged 25-74 between the Years 1981 and 2006
- (2010) Thor Aspelund et al. PLoS One
- Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170 255 patients from 76 randomized trials
- (2010) E. J. Mills et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD
- (2010) M. Hoogendoorn et al. THORAX
- The Modeled Lifetime Cost-Effectiveness of Published Adherence-Improving Interventions for Antihypertensive and Lipid-Lowering Medications
- (2010) Richard H. Chapman et al. VALUE IN HEALTH
- Effects on Coronary Heart Disease of Increasing Polyunsaturated Fat in Place of Saturated Fat: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- (2010) Dariush Mozaffarian et al. PLOS MEDICINE
- A Systematic Review of the Evidence Supporting a Causal Link Between Dietary Factors and Coronary Heart Disease
- (2009) Andrew Mente et al. ARCHIVES OF INTERNAL MEDICINE
- Relationships of HDL Cholesterol, ApoA-I, and ApoA-II With Homocysteine and Creatinine in Patients With Type 2 Diabetes Treated With Fenofibrate
- (2009) Marja-Riitta Taskinen et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Omega-6 Fatty Acids and Risk for Cardiovascular Disease
- (2009) William S. Harris et al. CIRCULATION
- Targets of Statin Therapy: LDL Cholesterol, Non-HDL Cholesterol, and Apolipoprotein B in Type 2 Diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS)
- (2009) V. Charlton-Menys et al. CLINICAL CHEMISTRY
- Severe hypertriglyceridemia and pancreatitis: presentation and management
- (2009) Nils Ewald et al. CURRENT OPINION IN LIPIDOLOGY
- Effects of a Plant-Based High-Carbohydrate/High-Fiber Diet Versus High-Monounsaturated Fat/Low-Carbohydrate Diet on Postprandial Lipids in Type 2 Diabetic Patients
- (2009) C. De Natale et al. DIABETES CARE
- Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002
- (2009) Lena Björck et al. EUROPEAN HEART JOURNAL
- Re-evaluating the Rose approach: comparative benefits of the population and high-risk preventive strategies
- (2009) Marie-Therese Cooney et al. EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION
- Health effects of trans-fatty acids: experimental and observational evidence
- (2009) D Mozaffarian et al. EUROPEAN JOURNAL OF CLINICAL NUTRITION
- Fibrates in the prevention of cardiovascular disease in patients with type 2 diabetes mellitus – A pooled meta-analysis of randomized placebo-controlled clinical trials
- (2009) Sandeep A. Saha et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
- (2009) Pia R. Kamstrup JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genetic Loci Associated With C-Reactive Protein Levels and Risk of Coronary Heart Disease
- (2009) Paul Elliott JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
- (2009) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
- (2009) Kimber L. Stanhope et al. JOURNAL OF CLINICAL INVESTIGATION
- Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database
- (2009) Philip J. Barter et al. JOURNAL OF LIPID RESEARCH
- Efficacy of Atorvastatin Reload in Patients on Chronic Statin Therapy Undergoing Percutaneous Coronary Intervention
- (2009) Germano Di Sciascio et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Novel Approaches for Preventing or Limiting Events (Naples) II Trial
- (2009) Carlo Briguori et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Value and Limitations of Existing Scores for the Assessment of Cardiovascular Risk
- (2009) Marie Therese Cooney et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Contraceptive Hormone Use and Cardiovascular Disease
- (2009) Chrisandra L. Shufelt et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
- (2009) Jennifer G. Robinson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Testing the inflammatory hypothesis of atherothrombosis: scientific rationale for the cardiovascular inflammation reduction trial (CIRT)
- (2009) PAUL M. RIDKER JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
- (2009) Paul M Ridker et al. LANCET
- Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial
- (2009) Kushwin Rajamani et al. LANCET
- Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention
- (2009) Pierre Amarenco et al. LANCET NEUROLOGY
- Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia
- (2009) Fawaz Almutairi et al. LIVER TRANSPLANTATION
- Fluvastatin and Perioperative Events in Patients Undergoing Vascular Surgery
- (2009) Olaf Schouten et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
- (2009) Robert Clarke et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
- (2009) Bengt C. Fellström et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Efficacy and Tolerability of Ezetimibe in Cardiac Transplant Recipients Taking Cyclosporin
- (2009) Steven M. Shaw et al. TRANSPLANTATION
- Transferability of Economic Evaluations Across Jurisdictions: ISPOR Good Research Practices Task Force Report
- (2009) Michael Drummond et al. VALUE IN HEALTH
- Prognosis and Risk Factors in Patients With Asymptomatic Aortic Stenosis and Their Modulation by Atorvastatin (20 mg)
- (2008) Wolfgang Dichtl et al. AMERICAN JOURNAL OF CARDIOLOGY
- Effect of Xuezhikang, an Extract From Red Yeast Chinese Rice, on Coronary Events in a Chinese Population With Previous Myocardial Infarction
- (2008) Zongliang Lu et al. AMERICAN JOURNAL OF CARDIOLOGY
- Mechanism of Action of Niacin
- (2008) Vaijinath S. Kamanna et al. AMERICAN JOURNAL OF CARDIOLOGY
- Cost Effectiveness of Community-Based Physical Activity Interventions
- (2008) Larissa Roux et al. AMERICAN JOURNAL OF PREVENTIVE MEDICINE
- Mammalian Target of Rapamycin Inhibitor Dyslipidemia in Kidney Transplant Recipients
- (2008) B. L. Kasiske et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events
- (2008) Samia Mora et al. CIRCULATION
- Estimation of LDL-Associated Apolipoprotein B from Measurements of Triglycerides and Total Apolipoprotein B
- (2008) A. M. Baca et al. CLINICAL CHEMISTRY
- Cost-effectiveness of statins in the prevention of coronary heart disease events in middle-aged Finnish men
- (2008) Piia Peura et al. CURRENT MEDICAL RESEARCH AND OPINION
- Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
- (2008) R. Scott et al. DIABETES CARE
- Combination statin-fibrate therapy: safety aspects
- (2008) R. Franssen et al. DIABETES OBESITY & METABOLISM
- Association of Loss-of-Function Mutations in the ABCA1 Gene With High-Density Lipoprotein Cholesterol Levels and Risk of Ischemic Heart Disease
- (2008) Ruth Frikke-Schmidt JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials
- (2008) A. Pandor et al. JOURNAL OF INTERNAL MEDICINE
- Apolipoprotein E: structure determines function, from atherosclerosis to Alzheimer's disease to AIDS
- (2008) Robert W. Mahley et al. JOURNAL OF LIPID RESEARCH
- Effect of Diabetes on Progression of Coronary Atherosclerosis and Arterial Remodeling
- (2008) Stephen J. Nicholls et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
- (2008) Edward J. Mills et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis
- (2008) LANCET
- Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
- (2008) GISSI-HF investigators LANCET
- Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
- (2008) GISSI-HF investigators LANCET
- Intensive Lipid Lowering with Simvastatin and Ezetimibe in Aortic Stenosis
- (2008) Anne B. Rossebø et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
- (2008) Paul M Ridker et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetically Elevated C-Reactive Protein and Ischemic Vascular Disease
- (2008) Jeppe Zacho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance
- (2008) Giovanni Annuzzi et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Non-pharmacological control of plasma cholesterol levels
- (2008) Andrea Poli et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Impact of progressive resistance training on lipids and lipoproteins in adults: A meta-analysis of randomized controlled trials
- (2008) George A. Kelley et al. PREVENTIVE MEDICINE
- The Clinical and Economic Burden of Nonadherence with Antihypertensive and Lipid-Lowering Therapy in Hypertensive Patients
- (2008) Spencer B. Cherry et al. VALUE IN HEALTH
- Relative Safety of Gemfibrozil and Fenofibrate in the Absence of Concomitant Cerivastatin Use
- (2007) Noa Holoshitz et al. AMERICAN JOURNAL OF CARDIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search